(August 20, 2020- Washington, D.C.) – The Puerto Rico Federal Affairs Administration (PRFAA) and Rear Admiral Peter J. Brown visited the island to promote the manufacturing industry in Puerto Rico. The visit was coordinated in partnership with the Resident Commissioner, Jenniffer González-Colón, and officials on the island. Rear Admiral Brown, White House Special Representative to Puerto Rico, and officials from the White House, the Development Finance Corporation, and the U.S. Environmental Protection Agency (EPA), visited the island to experience firsthand Puerto Rico’s capabilities and potential to become a Caribbean hub in the pharmaceutical and medical device manufacturing industry.
Rear Admiral Brown participated in meetings joined by the Executive Director of the Puerto Rico Federal Affairs Administration, Jennifer M. Storipan, Esq.; Deputy Director, Juan Leonardo Negrón Díaz; Resident Commissioner, Jenniffer González- Colón; Chris Abbott, Senior Policy Analyst at the White House; Juan Caro, Special Advisor of the White House and Department of Energy; Eric Jones, Development Finance Corporation, Alex Amparo, Federal Disaster Recovery Coordinator, Federal Management Emergency Agency; Alejandro De La Campa, Acting Deputy Federal Disaster Recovery Coordinator, Federal Management Emergency Agency; Doug Benevento, Associate Deputy Administrator, Environmental Protection Agency; and Peter D. López, Regional Administrator, Environmental Protection Agency.
This visit builds upon Admiral Brown’s trips over the past year to discuss the revitalization of the island, ongoing federal projects, preparedness and readiness for the 2020 hurricane season, and economic development for Puerto Rico. As the island continues to recover from the 2017 hurricanes, Irma and María, the recent earthquakes that continue to impact the island, and the ongoing Coronavirus COVID-19 pandemic, will all be issues at the forefront of this trip.
Furthermore, this visit included meetings with the GK Pharmaceutical, Honeywell Industries, Lufthansa Technik, Copan Industries, Pfizer, Skalar, and GSK. Additionally, there was a pharma industry roundtable and a virtual working section with the manufacturing industry. Tomorrow, officials are expected to visit environmental sites with the EPA and discuss disaster recovery efforts, engage in a dialogue with several communities on the drinking water system, and the recycling industry.
“As we continue to battle the COVID-19 pandemic, it is vital that our Nation reestablishes U.S. biomedical production to reduce its dependence on the foreign supply chain. PRFAA has been working with White House officials and federal agencies so that together we can bring back manufacturing to Puerto Rico and the island can become the Caribbean hub in the pharmaceutical and medical device manufacturing market,” said the Executive Director of the Puerto Rico Federal Affairs Administration (PRFAA) Jennifer M. Storipan, Esq. “Puerto Rico is a leader in biomedical production, and it is important for us that federal officials and stakeholders experience firsthand the potential our island has to offer”.